Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Diabetes Spectrum is Scopus-indexed (Q2, CiteScore 3.9). Published by American Diabetes Association Inc..
Checked against the index lists dated .
ISSN 1040-9165Verify ISSN ↗1944-7353Verify ISSN ↗
Publisher: American Diabetes Association Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 74 / 179 | 58th | Q2 |
| Endocrinology, Diabetes and Metabolism | 138 / 250 | 45th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–2025, best quartile Q2, CiteScore 3.9.
Diabetes Spectrum is Q2 in Internal Medicine (rank 74 of 179) and Q3 in Endocrinology, Diabetes and Metabolism (rank 138 of 250), by CiteScore 2025.
Diabetes Spectrum is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 3.9, quartile Q2, 58th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.293, quartile Q1, with an H-index of 52.
Diabetes Spectrum is published by American Diabetes Association Inc. Its print ISSN is 1040-9165 and its online ISSN is 1944-7353.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Diabetes Spectrum has an h-index of 70 and a 2-year mean of 4.16 citations per paper (OpenAlex). Its Scopus CiteScore is 3.9, quartile Q2. On 2-year citations it ranks #31 of 172 Scopus journals in Internal Medicine.
Diabetes Spectrum published 68 papers in 2025; its busiest recent year was 2022 with 72. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 86 research articles (2024–2025), authors are most often from United States (82.2%), Denmark (2.9%) and Canada (2.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.